IL86632A0 - Derivatives substituted at methyl-amino nitrogen - Google Patents

Derivatives substituted at methyl-amino nitrogen

Info

Publication number
IL86632A0
IL86632A0 IL86632A IL8663288A IL86632A0 IL 86632 A0 IL86632 A0 IL 86632A0 IL 86632 A IL86632 A IL 86632A IL 8663288 A IL8663288 A IL 8663288A IL 86632 A0 IL86632 A0 IL 86632A0
Authority
IL
Israel
Prior art keywords
methyl
amino nitrogen
derivatives substituted
formula
stau
Prior art date
Application number
IL86632A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL86632A0 publication Critical patent/IL86632A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Abstract

N-Substituted derivatives of staurosporin of the formula [Stau]-N(CH3)-R (I> in which [Stau] represents the radical of the sub-formula <IMAGE> in which R represents a hydrocarbyl R<0> or an acyl Ac, which preferably have at most 30 C atoms, and salts of compounds of the formula I having salt-forming properties, are distinguished as selective inhibitors of protein kinase C. They are prepared by conventional alkylation or acylation of staurosporin.
IL86632A 1987-06-15 1988-06-06 Derivatives substituted at methyl-amino nitrogen IL86632A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH224487 1987-06-15
CH144088 1988-04-19

Publications (1)

Publication Number Publication Date
IL86632A0 true IL86632A0 (en) 1988-11-30

Family

ID=25687663

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86632A IL86632A0 (en) 1987-06-15 1988-06-06 Derivatives substituted at methyl-amino nitrogen

Country Status (20)

Country Link
EP (1) EP0296110B1 (en)
JP (1) JP2708047B2 (en)
KR (1) KR970001529B1 (en)
AT (1) ATE134375T1 (en)
AU (1) AU617324B2 (en)
CA (1) CA1337763C (en)
DE (1) DE3855015D1 (en)
DK (1) DK175507B1 (en)
ES (1) ES2083956T3 (en)
FI (1) FI89362C (en)
GR (1) GR3019064T3 (en)
HK (1) HK1003788A1 (en)
HU (1) HU201329B (en)
IE (1) IE70523B1 (en)
IL (1) IL86632A0 (en)
MY (1) MY104316A (en)
NO (1) NO170634C (en)
NZ (1) NZ225018A (en)
PT (1) PT87719B (en)
YU (1) YU115488A (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (en) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd Ucn-01 and production thereof
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
SK278989B6 (en) * 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituted pyrroles, their use for producing a drug, and the drug on their base
USRE36736E (en) * 1989-02-06 2000-06-13 Hoffman-La Roche Inc. Substituted pyrroles
DE3924538A1 (en) * 1989-07-25 1991-01-31 Goedecke Ag INDOLOCARBAZOL AND THEIR USE
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
AU2866992A (en) * 1991-10-10 1993-05-03 Schering Corporation 4'-(n-substituted-n-oxide)staurosporine derivatives
EP0541486A1 (en) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclic conjugates
WO1993018771A1 (en) * 1992-03-24 1993-09-30 Asahi Kasei Kogyo Kabushiki Kaisha PLATELET AGGLUTINATION INHIBITOR CONTAINING STAUROSPORINE η-LACTAM DERIVATIVE
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5621100A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. K-252a derivatives for treatment of neurological disorders
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5674867A (en) * 1992-09-21 1997-10-07 Kyowa Hakko Kogyo Co., Ltd. Indolocarbazole derivatives and therapeutic method for stimulating megakaicyocyte production
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP2298310A3 (en) 1993-01-28 2011-04-06 Boston Scientific Limited Therapeutic inhibitors of vascular smooth muscle cells
PH30300A (en) * 1993-05-07 1997-01-20 Ciba Geigy Ag Polycyclic compounds and processes for the preparation thereof
JPH09503381A (en) * 1993-07-09 1997-04-08 ジ・インスティテュート・オブ・キャンサー・リサーチ Protein tyrosine kinase and its ligand
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
EP0711556A1 (en) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenous solutions containing staurosporine derivatives
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
AU721942B2 (en) 1996-06-25 2000-07-20 Cephalon, Inc. Use of K-252A derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
WO1998043618A2 (en) 1997-03-31 1998-10-08 Neorx Corporation Use of cytoskeletal inhibitors for the prevention of restenosis
CN1172673C (en) * 1998-11-23 2004-10-27 诺瓦提斯公司 Use of staurosporine derivatives for treating ocular neovascular diseases
CA2994779C (en) 2001-02-19 2020-08-25 Novartis Ag Use of 40-o-(2-hydroxyethyl)-rapamycin for inhibiting growth of a solid tumour of the brain other than lymphatic cancer
BR0209647A (en) 2001-05-16 2004-07-27 Novartis Ag A combination comprising n- {5- [4- (4-methyl-piperazine-methyl) -benzoylamido] -2-methyl-phenyl} -4- (3-pyridyl) -2-pyrimidine-amine and a chemotherapeutic agent
PT1441737E (en) 2001-10-30 2006-12-29 Dana Farber Cancer Inst Inc Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
PL372103A1 (en) 2002-05-16 2005-07-11 Novartis Ag Use of edg receptor binding agents in cancer
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
CL2004001120A1 (en) 2003-05-19 2005-04-15 Irm Llc COMPOUNDS DERIVED FROM AMINA REPLACED WITH HETEROCICLES, IMMUNOSUPPRESSORS; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT DISEASES MEDIATED BY LYMPHOCYTE INTERACTIONS, SUCH AS AUTOIMMUNE, INFLAMMATORY, INFECTIOUS, CANCER DISEASES.
US20040246627A1 (en) * 2003-06-06 2004-12-09 Durrum Thomas M. Disc drive pivot bearing assembly
AU2004262927B2 (en) 2003-08-08 2008-05-22 Novartis Ag Combinations comprising staurosporines
TW200538433A (en) 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
CN101010082A (en) * 2004-08-31 2007-08-01 诺瓦提斯公司 Use of midostaurin for treating gastrointestinal stromal tumors
JO2897B1 (en) * 2004-11-05 2015-09-15 نوفارتيس ايه جي Organic compounds
PT2275103E (en) 2005-11-21 2014-07-24 Novartis Ag Mtor inhibitors in the treatment of endocrine tumors
RU2011129230A (en) 2008-12-18 2013-01-27 Новартис Аг NEW POLYMORPHIC FORM 1- [4- [1- (4-Cyclohexyl-3-trifluoromethylbenzyloxylimino) Ethyl] -2-Ethylbenzyl] Azetidine-3-Carboxylic Acid
CN103204794A (en) 2008-12-18 2013-07-17 诺瓦提斯公司 New Salts
UY32330A (en) 2008-12-18 2010-07-30 Novartis Ag NEW FORM OF SALT OF ACID 1- (4- {1- [E-4-CICLOHEXIL-3-TRIFLUORO-METIL-BENCILOXI-IMINO] -ETIL} -2-ETIL-BENCIL) -AZETIDIN-3-CARBOXYLICAL, POLYMODIC FORMS , PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
EP2327706A1 (en) * 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2847191B1 (en) 2012-05-09 2016-06-15 Sanofi Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
US20220395553A1 (en) 2019-11-14 2022-12-15 Cohbar, Inc. Cxcr4 antagonist peptides
IT202000004291A1 (en) * 2020-03-02 2021-09-02 Indena Spa PROCESS FOR THE PURIFICATION OF CARBAZOLIC INDOLE ALKALOIDS
CN112812129A (en) * 2020-12-31 2021-05-18 浙江海正药业股份有限公司 Novel crystalline form of midostaurin, process for its preparation and its use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives

Also Published As

Publication number Publication date
KR890000494A (en) 1989-03-15
YU115488A (en) 1989-12-31
PT87719A (en) 1988-07-01
GR3019064T3 (en) 1996-05-31
DK324888A (en) 1988-12-16
ES2083956T3 (en) 1996-05-01
HU201329B (en) 1990-10-28
DK175507B1 (en) 2004-11-15
FI882808A (en) 1988-12-16
ATE134375T1 (en) 1996-03-15
AU617324B2 (en) 1991-11-28
FI882808A0 (en) 1988-06-13
JP2708047B2 (en) 1998-02-04
EP0296110A2 (en) 1988-12-21
EP0296110A3 (en) 1991-02-27
FI89362C (en) 1993-09-27
CA1337763C (en) 1995-12-19
NZ225018A (en) 1990-09-26
EP0296110B1 (en) 1996-02-21
AU1757188A (en) 1988-12-15
NO882613L (en) 1988-12-16
IE881787L (en) 1988-12-15
KR970001529B1 (en) 1997-02-11
DE3855015D1 (en) 1996-03-28
HUT47587A (en) 1989-03-28
MY104316A (en) 1994-03-31
IE70523B1 (en) 1996-12-11
PT87719B (en) 1992-10-30
JPS6434989A (en) 1989-02-06
NO170634B (en) 1992-08-03
FI89362B (en) 1993-06-15
DK324888D0 (en) 1988-06-14
NO170634C (en) 1992-11-11
HK1003788A1 (en) 1998-11-06
NO882613D0 (en) 1988-06-14

Similar Documents

Publication Publication Date Title
IL86632A0 (en) Derivatives substituted at methyl-amino nitrogen
HK15397A (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
HU9302330D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
GR3018557T3 (en) Hydantoin derivatives.
BE888778A (en) PROCESS FOR THE PREPARATION OF AN EGG WHITE SUBSTITUTE BASED ON SOY PROTEIN
SE8502017D0 (en) 1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES AND SALTS THEREOF, PROCESS FOR PRODUCING THE SAME AND ANTIBACTERIAL AGENTS COMPRISING THE SAME
MA22540A1 (en) SUBSTITUTED DIAMINOPHTHALIMIDES AND SIMILAR DERIVATIVES.
MA22251A1 (en) PROCESS FOR THE PREPARATION OF PIPERIDINE DERIVATIVES SUBSTITUTED IN POSITION 3
FR2626572B1 (en) PROCESS FOR THE ALKYLATION OF ALIPHATIC HYDROCARBONS
GR3034888T3 (en) Special chemiluminescent acridine derivatives and their use in luminescence immunoassays.
FR2627493B1 (en) PROCESS FOR THE PREPARATION OF ISOQUINOLEIN DERIVATIVES
GR3003738T3 (en)
FR2632521B1 (en) NOVEL PHENOTHIAZINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2632952B1 (en) PROCESS FOR THE PREPARATION OF ARYLSULFONYL ISOCYANATES AND DERIVATIVES THEREOF
ES503895A0 (en) PROCEDURE FOR PREPARING 3B-HIDROXIMETIL-4A-HIDROXI-8B- ALCOXI-2,9-DIOXATRICICLO (4,3,1,03,7) DEAN
MA23081A1 (en) PROCESS FOR THE PREPARATION OF INDOLONE DERIVATIVES
FR2555578B1 (en) PROCESS FOR THE PREPARATION OF AZETIDINONE DERIVATIVES
ES8505363A1 (en) 1,4-Dihydropyridine derivatives.
FR2659650B1 (en) PROCESS FOR THE PREPARATION OF N-PHENYL N &#39;- (CYCLO) ALKYL PARAPHNYLENE DIAMINES.
FR2572072B1 (en) PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES
FR2618781B2 (en) PROCESS FOR THE PREPARATION OF DERIVATIVES OF 4,4-DIMETHYL TETRAHYDRO PYR-2-ONE
RO92697A2 (en) PROCESS FOR THE PREPARATION OF COUMARIN DERIVATIVES
FR2620449B1 (en) PROCESS FOR THE PREPARATION OF BENZODIAZEPINE-1,4 ONE-2 DERIVATIVES
CS18189A1 (en) Basically substituted 2,3-dichlorodiphenylmethane derivatives of their salts
MX12187A (en) PROCEDURE FOR PREPARING DERIVATIVES OF 2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONA

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired